
Multidisciplinary Case Conference in Psoriatic Arthritis: Enhancing Outcomes with Oral Targeted Therapies
Elevate your PsA care! Join this Multidisciplinary Care Discussion to explore cutting-edge strategies for enhancing patient outcomes with oral targeted therapies. Master PDE4, JAK, and TYK2 inhibitors to optimize safety and efficacy.
- Price
- Free
- Accredited provider:
- i3 Health
- Learning platform:
- IQ Apparatus
- Release date
- March 17, 2026
- Expires
- March 16, 2027